Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

What does the Nu.Q® Vet Cancer Test measure?

Monday, January 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article features Dr. Sue Ettinger discussing the Nu.Q® Vet Cancer Test, which assesses cancer risk in dogs. The test is part of Volition's innovative technology aimed at improving veterinary diagnostics. Additionally, there are upcoming publications and milestones related to the test's application in cats and its automation with Fujifilm Vet Systems.
Price reaction · baseline $20.6 (2024-01-22T15:43:00.000Z) · hit during market hours · 10 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-3%

Market Sentiment Analysis

POSITIVE FACTORS

  • The Nu.Q® Vet Cancer Test shows promise in measuring cancer risk in dogs.
  • The technology is backed by expert Dr. Sue Ettinger, enhancing credibility.
  • Recent advancements include an automated version of the test.

Full Press Release Details

Watch our short video, featuring Dr. Sue Ettinger, aka Dr. Sue Cancer Vet, as she explains the science behind our technology, and what our Nu.Q ® Vet Cancer Test measures to determine the risk of cancer in a canine patient.

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What does the Nu.Q® Vet Cancer Test measure?

The Nu.Q® Vet Cancer Test measures the risk of cancer in canine patients.

Who explains the Nu.Q® Vet Cancer Test?

Dr. Sue Ettinger, known as Dr. Sue Cancer Vet, explains the test.

What recent advancements have been made?

Volition announced the first automated version of the Nu.Q® Vet Cancer Test.

Is there a study related to cats?

Yes, a manuscript for the Nu.Q® Vet Cancer Test in cats has been submitted.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q Vet Cancer Test Volition cancer detection canine health Dr. Sue Ettinger
Last updated: Jan 22, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk